Valeant Ups Takeover Bid For Allergan

by Fox Business, Benzinga Contributor
May 28, 2014 10:54 AM | 5 seconds read |

Valeant sweetened its takeover bid for Botox maker Allergan, offering to buy the company for $49.4 billion.

Market News and Data brought to you by Benzinga APIs

© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Comments
Posted In: NewsM&A
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!